SG11201607478RA - New use of n,n-bis-2-mercaptoethyl isophthalamide - Google Patents

New use of n,n-bis-2-mercaptoethyl isophthalamide

Info

Publication number
SG11201607478RA
SG11201607478RA SG11201607478RA SG11201607478RA SG11201607478RA SG 11201607478R A SG11201607478R A SG 11201607478RA SG 11201607478R A SG11201607478R A SG 11201607478RA SG 11201607478R A SG11201607478R A SG 11201607478RA SG 11201607478R A SG11201607478R A SG 11201607478RA
Authority
SG
Singapore
Prior art keywords
bis
new use
mercaptoethyl isophthalamide
isophthalamide
mercaptoethyl
Prior art date
Application number
SG11201607478RA
Other languages
English (en)
Inventor
Boyd Eugene Haley
Ragnar Axel Theodor Klingberg
Original Assignee
Emeramed Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50776843&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SG11201607478R(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Emeramed Ltd filed Critical Emeramed Ltd
Publication of SG11201607478RA publication Critical patent/SG11201607478RA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/095Sulfur, selenium, or tellurium compounds, e.g. thiols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/10Expectorants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/14Antitussive agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
SG11201607478RA 2014-04-04 2015-03-31 New use of n,n-bis-2-mercaptoethyl isophthalamide SG11201607478RA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB1406115.4A GB2524831A (en) 2014-04-04 2014-04-04 New pharmaceutical use
PCT/GB2015/050999 WO2015150793A1 (en) 2014-04-04 2015-03-31 New use of n,n-bis-2-mercaptoethyl isophthalamide

Publications (1)

Publication Number Publication Date
SG11201607478RA true SG11201607478RA (en) 2016-10-28

Family

ID=50776843

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201607478RA SG11201607478RA (en) 2014-04-04 2015-03-31 New use of n,n-bis-2-mercaptoethyl isophthalamide

Country Status (35)

Country Link
US (1) US9782368B2 (ja)
EP (1) EP3125876B8 (ja)
JP (1) JP6474423B2 (ja)
KR (1) KR102482699B1 (ja)
CN (1) CN106132405B (ja)
AU (1) AU2015242374B2 (ja)
BR (1) BR112016022880B1 (ja)
CA (1) CA2944113C (ja)
CL (1) CL2016002499A1 (ja)
CY (1) CY1121235T1 (ja)
DK (1) DK3125876T3 (ja)
EA (1) EA032116B1 (ja)
EC (1) ECSP16078100A (ja)
ES (1) ES2659174T3 (ja)
GB (1) GB2524831A (ja)
HR (1) HRP20180325T1 (ja)
HU (1) HUE036206T2 (ja)
IL (1) IL248027B (ja)
LT (1) LT3125876T (ja)
MA (1) MA39833B1 (ja)
ME (1) ME03012B (ja)
MX (1) MX2016012591A (ja)
NO (1) NO3125876T3 (ja)
NZ (1) NZ724678A (ja)
PE (1) PE20170586A1 (ja)
PH (1) PH12016501975A1 (ja)
PL (1) PL3125876T3 (ja)
PT (1) PT3125876T (ja)
RS (1) RS56905B1 (ja)
SA (1) SA516371966B1 (ja)
SG (1) SG11201607478RA (ja)
SI (1) SI3125876T1 (ja)
UA (1) UA119558C2 (ja)
WO (1) WO2015150793A1 (ja)
ZA (1) ZA201606406B (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7201989B2 (ja) 2018-10-22 2023-01-11 株式会社松井製作所 粉粒体材料の貯留装置
GB202005057D0 (en) 2020-04-06 2020-05-20 Emeramed Ltd New Use

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6586600B2 (en) 2000-12-06 2003-07-01 University Of Kentucky Research Foundation Multidentate sulfur-containing ligands
JP2011026204A (ja) * 2007-11-26 2011-02-10 Rei Furukawa タバコの煙を吸入することにより引き起こされる疾患の予防及び/又は治療用組成物
US8950583B2 (en) * 2008-12-06 2015-02-10 Ermes Medical Company Limited Method to remove heavy metals from a mammal
US8575218B2 (en) * 2009-09-28 2013-11-05 The University Of Kentucky Research Foundation Thiol-containing compounds for the removal of elements from tissues and formulations therefor
RU2528396C2 (ru) 2009-09-28 2014-09-20 Юнивёрсити Оф Кентукки Рисёч Фаундейшн Тиолсодержащие соединения для удаления элементов из загрязненной окружающей среды и способы их применения
US8426368B2 (en) 2010-03-25 2013-04-23 The University Of Kentucky Research Foundation Method of ameliorating oxidative stress and supplementing the diet
US20110237776A1 (en) 2010-03-25 2011-09-29 Haley Boyd E Aromatic compounds with sulfur containing ligands

Also Published As

Publication number Publication date
MX2016012591A (es) 2017-04-06
KR102482699B1 (ko) 2022-12-28
CL2016002499A1 (es) 2017-01-27
SA516371966B1 (ar) 2019-04-14
CA2944113C (en) 2022-06-21
GB2524831A (en) 2015-10-07
KR20160140929A (ko) 2016-12-07
CY1121235T1 (el) 2020-05-29
PT3125876T (pt) 2018-02-22
NZ724678A (en) 2022-12-23
ECSP16078100A (es) 2018-03-31
PL3125876T3 (pl) 2018-05-30
CN106132405B (zh) 2019-06-18
BR112016022880B1 (pt) 2022-09-13
EA032116B1 (ru) 2019-04-30
EP3125876B8 (en) 2018-01-24
UA119558C2 (uk) 2019-07-10
JP6474423B2 (ja) 2019-02-27
PH12016501975A1 (en) 2017-01-09
MA39833B1 (fr) 2018-04-30
JP2017511307A (ja) 2017-04-20
ME03012B (me) 2018-10-20
LT3125876T (lt) 2018-02-12
CN106132405A (zh) 2016-11-16
US9782368B2 (en) 2017-10-10
EP3125876A1 (en) 2017-02-08
DK3125876T3 (en) 2018-01-15
US20170157072A1 (en) 2017-06-08
ES2659174T3 (es) 2018-03-14
PE20170586A1 (es) 2017-05-20
SI3125876T1 (en) 2018-04-30
HUE036206T2 (hu) 2018-06-28
IL248027B (en) 2019-03-31
BR112016022880A2 (ja) 2017-08-15
GB201406115D0 (en) 2014-05-21
ZA201606406B (en) 2018-04-25
AU2015242374A1 (en) 2016-10-13
RS56905B1 (sr) 2018-05-31
CA2944113A1 (en) 2015-10-08
EA201692013A1 (ru) 2017-03-31
AU2015242374B2 (en) 2019-10-10
EP3125876B1 (en) 2017-11-29
MA39833A (fr) 2017-02-08
WO2015150793A1 (en) 2015-10-08
HRP20180325T1 (hr) 2018-04-06
NO3125876T3 (ja) 2018-04-28

Similar Documents

Publication Publication Date Title
IL248856B (en) New treatment
GB201412290D0 (en) Novel use
IL250017A0 (en) Eye examination devices
GB201403944D0 (en) New use
GB201416727D0 (en) Use
GB201416716D0 (en) Use
GB201417497D0 (en) Novel use
IL248027B (en) A new use of n,n-bis-2-mercaptoethyl isophthalamide
IL264538B (en) A new use of n,n-bis-2-mercaptoethyl isophthalamide
GB201420095D0 (en) New use
ZA201702925B (en) New immunostimulatory compounds
GB201518831D0 (en) New use
GB201417499D0 (en) Novel use
GB201417500D0 (en) Novel use
GB201421960D0 (en) Use
GB201420534D0 (en) Use
GB201420535D0 (en) Use
GB201420365D0 (en) Use
GB201415170D0 (en) Novel use
GB201420970D0 (en) eGURE, egure, Egure
GB201412116D0 (en) Novel use
IL233408A0 (en) New Skin - Perineal
GB201417719D0 (en) New treatment
GB201409014D0 (en) Novel use
GB201409018D0 (en) Novel use